Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1712

BillFederalSenateIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
About This Bill
Committee
Latest Action · May 18, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
May 18, 2023
Cosponsors (1)
0D 1R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.